- Home
- CMPS vs CLPT Comparison
CMPS vs CLPT Comparison
Compare CMPS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- CLPT
- Stock Information
- Founded
- CMPS 2020
- CLPT 1998
- Country
- CMPS United Kingdom
- CLPT United States
- Employees
- CMPS N/A
- CLPT N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- CMPS Health Care
- CLPT Health Care
- Exchange
- CMPS Nasdaq
- CLPT Nasdaq
- Market Cap
- CMPS 322.5M
- CLPT 370.5M
- IPO Year
- CMPS 2020
- CLPT N/A
- Fundamental
- Price
- CMPS $2.79
- CLPT $13.09
- Analyst Decision
- CMPS Strong Buy
- CLPT Strong Buy
- Analyst Count
- CMPS 7
- CLPT 3
- Target Price
- CMPS $21.83
- CLPT $25.00
- AVG Volume (30 Days)
- CMPS 1.0M
- CLPT 237.8K
- Earning Date
- CMPS 05-07-2025
- CLPT 05-06-2025
- Dividend Yield
- CMPS N/A
- CLPT N/A
- EPS Growth
- CMPS N/A
- CLPT N/A
- EPS
- CMPS N/A
- CLPT N/A
- Revenue
- CMPS N/A
- CLPT $31,390,000.00
- Revenue This Year
- CMPS N/A
- CLPT $24.28
- Revenue Next Year
- CMPS N/A
- CLPT $42.11
- P/E Ratio
- CMPS N/A
- CLPT N/A
- Revenue Growth
- CMPS N/A
- CLPT 31.04
- 52 Week Low
- CMPS $2.69
- CLPT $5.11
- 52 Week High
- CMPS $10.31
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- CMPS 31.50
- CLPT 45.45
- Support Level
- CMPS $2.88
- CLPT $11.32
- Resistance Level
- CMPS $3.16
- CLPT $14.01
- Average True Range (ATR)
- CMPS 0.21
- CLPT 0.70
- MACD
- CMPS -0.03
- CLPT 0.06
- Stochastic Oscillator
- CMPS 9.30
- CLPT 65.80
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.